During epithelial-to-mesenchymal transition (EMT) in ovarian carcinoma, there is downregulation of E-cadherin expression which is located at cell adherent junctions, upregulation of N-cadherin expression and upregulation in the mesenchymal marker of vimentin (Ray et al., 2023). The gene discussed is CDH2; the disease is ovarian carcinoma.